Laboratory research materials for in vitro use only.

$20 flat-rate shipping across Canada  ·  Free shipping on orders over $350

KPV

For laboratory research use only (in vitro). Not for human or animal use.

15% OFF Create an account and get 15% off your first order
Select Size — Price Per Vial
In Stock — Ships Today
Restock — Pre-Order (25% Off)

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$53.99Your price
3-4 units5% off$51.29Your price
5-9 units10% off$48.59Your price
10+ units Best Value15% off$45.89Your price

25% Pre-Order Discount Applied

The 25% pre-order discount is the maximum available and overrides volume pricing. There is no additional volume discount.

Pay via Interac e-Transfer

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

Interac e-Transfer

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence Lys-Pro-Val
Molecular Weight 342.4 Da
Molecular Formula C16H30N4O4
CAS Number 67727-97-3
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Preclinical

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

KPV is a naturally occurring anti-inflammatory tripeptide with the amino acid sequence Lys-Pro-Val, a molecular formula of C16H30N4O4, and a molecular weight of 342.4 Da (CAS number 67727-97-3). KPV is derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH) and retains the parent molecule’s anti-inflammatory activity while operating through melanocortin receptor-independent mechanisms.

KPV is also referred to as the Alpha-MSH C-terminal tripeptide or KPV tripeptide. Its small size and demonstrated transport via the intestinal PepT1 peptide transporter make it a compound of particular interest in gastrointestinal inflammation research.

Property Value
Molecular Formula C16H30N4O4
Molecular Weight 342.4 Da
CAS Number 67727-97-3
Sequence Lys-Pro-Val
Research Status Preclinical

Research Overview

KPV has been investigated in preclinical research focusing on anti-inflammatory signaling, inflammatory bowel disease models, and NF-kB pathway modulation. The central mechanism involves inhibition of the nuclear factor kappa-B (NF-kB) signaling pathway, the master transcriptional regulator of inflammatory gene expression. KPV inhibits the activation of the IKK complex, preventing phosphorylation and degradation of IkB-alpha and keeping NF-kB sequestered in the cytoplasm.

Critically, KPV exerts these anti-inflammatory effects independently of melanocortin receptors (MC1R-MC5R), distinguishing it from the full-length alpha-MSH peptide. The compound is transported into intestinal epithelial cells via the PepT1 (SLC15A1) transporter, enabling intracellular delivery in the gastrointestinal mucosa.

Key areas of published research include:

  • Inflammatory Bowel Disease: Preclinical studies in colitis models have demonstrated that KPV reduces intestinal inflammation through NF-kB inhibition in epithelial cells. The PepT1-mediated transport mechanism enables direct uptake by intestinal epithelium, supporting topical gastrointestinal applications.
  • NF-kB Pathway Modulation: Research has characterized KPV’s inhibition of the IKK-IkB-NF-kB cascade, demonstrating reduced expression of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), chemokines, and adhesion molecules in multiple cell types.
  • Anti-Inflammatory Signaling: KPV has shown anti-inflammatory activity across diverse cell types and inflammation models, with effects comparable to full-length alpha-MSH despite lacking melanocortin receptor binding.

KPV remains a preclinical research compound with no regulatory approvals.

Specifications

All KPV supplied by Prescott Bio Canada is manufactured to research-grade standards.

Specification Detail
Purity >98% (HPLC)
Form Lyophilized powder
Appearance White to off-white powder
Storage (lyophilized) -20°C, protected from light
Storage (reconstituted) 2-8°C, use within 30 days
Solubility Soluble in bacteriostatic water, sterile water, or normal saline

Each vial is accompanied by a Certificate of Analysis (COA) documenting purity, identity, and endotoxin testing.

Research Applications

KPV is supplied exclusively for in vitro and in vivo laboratory research. Published experimental applications include:

  • NF-kB signaling pathway inhibition and anti-inflammatory mechanism research
  • Inflammatory bowel disease and colitis model studies
  • PepT1 transporter biology and intestinal peptide uptake research
  • Cytokine modulation and immune regulation studies
  • Comparative studies with alpha-MSH and melanocortin receptor agonists

Researchers should consult the primary literature and institutional review protocols before designing experiments with KPV.

Storage and Handling

Lyophilized powder: Store at -20°C in the original sealed vial, protected from light and moisture. Under these conditions, KPV maintains stability for up to 24 months.

Reconstituted solution: Reconstitute with bacteriostatic water or sterile water to the desired concentration. Store reconstituted KPV at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

Handling precautions: This product is intended for research use only (RUO). Not for human or veterinary diagnostic or therapeutic use. Handle using standard laboratory safety practices including appropriate PPE.

Additional information

Size

5mg, 10mg, 30mg

Published Research

4 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. (2008). Gastroenterology. PubMed 18061177

Silencing of peptide transporter PepT1 reduces colitis in mice by targeting epithelial NF-kB signaling

Dalmasso G, Nguyen HT, Yan Y, et al. (2010). Gastroenterology

Functional nanoparticles for oral drug delivery of KPV peptide for colitis treatment

Laroui H, Dalmasso G, Nguyen HT, et al. (2010). Biomaterials. PubMed 19909746

Anti-inflammatory effects of alpha-MSH C-terminal peptide KPV

Ichiyama T, Sakai T, Catania A, et al. (1999). Peptides

For laboratory research use only (in vitro). Not for human or animal use.

Research Use Certification

This website supplies laboratory reference materials intended solely for in vitro research purposes. By entering, you confirm: